<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113883.3.464.1003.110.12.1044" displayName="Influenza Vaccine Administered" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="86198006" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Influenza vaccination (procedure)"/>            <ns0:Concept code="90655" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"/>            <ns0:Concept code="90657" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"/>            <ns0:Concept code="90661" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"/>            <ns0:Concept code="90662" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"/>            <ns0:Concept code="90673" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"/>            <ns0:Concept code="90685" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"/>            <ns0:Concept code="90686" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"/>            <ns0:Concept code="90687" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"/>            <ns0:Concept code="90688" codeSystem="2.16.840.1.113883.6.12" codeSystemName="CPT" codeSystemVersion="2019" displayName="Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"/>        </ns0:ConceptList>        <ns0:Source>National Committee for Quality Assurance</ns0:Source>        <ns0:Purpose>(Clinical Focus: This value set contains concepts that represent procedures for influenza vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant influenza vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)</ns0:Purpose>        <ns0:Definition>(2.16.840.1.113883.3.464.1003.110.11.1115:Influenza Vaccine Administered),(2.16.840.1.113883.3.464.1003.110.11.1116:Influenza Vaccine Administered)</ns0:Definition>        <ns0:Type>Grouping</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2017-05-04</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>